Novo Nordisk's Ozempic: Recent Study Reveals Potential Risk of Rare Vision Loss
Dec 13, 2024
146
Recent research suggests a potential link between Novo Nordisk's Ozempic and a rare vision impairment, NAION, urging patients to weigh therapeutic benefits against potential risks.